drugset / Trial / NCT06169982
A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to measure the activity and insulin time action of LY3209590 at steady state in participants with type 2 diabetes mellitus. The total study duration is approximately 182 days.
Timeline
- Start
- 2023-12-07
- Primary completion
- 2024-07-18
- Completion
- 2024-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin Efsitora Alfa | Protein / enzyme biologic | — | Subcutaneous |